The FDA Approves Aducanumab as a Treatment for Alzheimer’s
AduhelmTM is the first Alzheimer’s drug approved by the Food and Drug Administration (FDA) since 2003. The drug, Aducanumab, is a therapeutic drug that clinically demonstrates a potential to delay further decline from Alzheimer’s disease and is also the first…
